Evaluation of Patients With Gastrointestinal Disease
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study ID
- NCT05041374
- Status
- Recruiting
Conditions
- Gastrointestinal Diseases
- Lower GI Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Study Details
Background: Ongoing and future research projects that study gastrointestinal diseases depend on access to biological samples and clinical data. Researchers want to study people who are seen and treated for these diseases. This may help them assess and treat these diseases better in the future. Objective: To collect data and samples from people being seen and/or treated for gastrointestinal problems at NIH, to use in future research. Eligibility: Adults aged 18 and older who have known or suspected gastrointestinal disorders or need screening, treatment, or follow-up per current medical guidelines. Design: Participants will be screened with a physical exam. Their medical records will be reviewed. Participants will be seen by doctors based on the ailment they have. Their condition will be treated just like it would at a doctor s office. But the data and samples collected will be used for future research. Participants may give blood, urine, and/or stool samples. If participants have an endoscopy or colonoscopy as part of their standard care and samples are taken, they may be asked to give their leftover samples to NIH. Or, they may be asked to have extra samples taken for NIH to use. These samples may include gastric acid and/or tissue from the lining of the stomach or intestines. If samples are not taken as part of their standard care, they may be asked to have samples taken for NIH to use. Data will be stored at NIH. The data systems are password protected. Samples will be coded. Participants will take part in the study for as long as they agree to be seen for their disease....
Key Dates
- Start date
- Jan 4, 2022
- Status verified
- May 2026
- Primary completion
- Dec 31, 2035
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 4,000 participants (estimated)
Arms
- Arm: Study CohortPatients with known or suspected gastrointestinal disease
Primary Outcome Measure
To collect data and samples during clinical evaluation, treatment and follow-up of participants for future use in studies of gastrointestinal diseases. [ Time Frame: End of study ]
Central Contacts
- Beverly E Niles(301) 451-0659
- Sheila Kumar, M.D.(301) 496-9730
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
Find similar trials in Bethesda, MD
Related Studies
- The Clinical Impact and Outcomes of Interventional Endoscopy ProceduresEnrolling By Invitation · University of California, Irvine · Orange, California
- Immune Responses to GlutenRecruiting · Boston Children's Hospital · Aurora, Colorado
- Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient OutcomesEnrolling By Invitation · Brigham and Women's Hospital · Boston, Massachusetts
- First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorsPHASE1 · Recruiting · IDRX, Inc., a wholly owned subsidiary of GSK, LLC · Miami, Florida